Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

July 2015 Archives

Fluoroquinolone lawsuits backed by science

Numerous patients who allege that a fluoroquinolone antibiotic is linked to their peripheral neuropathy diagnosis are filing lawsuits nationwide against the makers of these drugs. A panel of federal judges meeting today in San Francisco will decide whether to transfer a lot of these federal fluoroquinolone lawsuits to one court, U.S. District Court for the Southern District of Illinois, for pretrial proceedings.

Fluoroquinolone lawsuits backed by science

Numerous patients who allege that a fluoroquinolone antibiotic is linked to their peripheral neuropathy diagnosis are filing lawsuits nationwide against the makers of these drugs. A panel of federal judges meeting today in San Francisco will decide whether to transfer a lot of these federal fluoroquinolone lawsuits to one court, U.S. District Court for the Southern District of Illinois, for pretrial proceedings.

New studies released on Xarelto bleeding

Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.

New studies released on Xarelto bleeding

Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.

Feds release truck safety proposal

The federal agency that administers the nation's highway safety program on Friday released advance notice of proposed rules aimed at improving single unit truck, or SUT, safety. The National Highway Traffic Safety Administration will accept comments from the general public and from transportation industry stakeholders concerning the "benefits, costs and other impacts" of two proposed crash protection requirements for single unit trucks:

Feds release truck safety proposal

The federal agency that administers the nation's highway safety program on Friday released advance notice of proposed rules aimed at improving single unit truck, or SUT, safety. The National Highway Traffic Safety Administration will accept comments from the general public and from transportation industry stakeholders concerning the "benefits, costs and other impacts" of two proposed crash protection requirements for single unit trucks:

Is lowering legal driving age the answer to trucker shortage?

Young drivers have a right to be on the road. The law in the state of Texas says so. But the law also includes a process called the graduated driver license program. The aim is to make sure that drivers grow into the privilege by restricting when they can drive and whom they can have in the vehicle with them. While they may be 16 when they first are licensed, the full fruits of having a license don't get realized until they're 18.

Is lowering legal driving age the answer to trucker shortage?

Young drivers have a right to be on the road. The law in the state of Texas says so. But the law also includes a process called the graduated driver license program. The aim is to make sure that drivers grow into the privilege by restricting when they can drive and whom they can have in the vehicle with them. While they may be 16 when they first are licensed, the full fruits of having a license don't get realized until they're 18.

Courts receive IVC filter lawsuits

In case after case detailing injuries patients sustained after receiving the surgically implanted inferior vena cava filter, plaintiffs in these product liability lawsuits have heaped upon the court scientific evidence of device failure rates. As IVC lawsuits continue to be filed across the nation, a federal panel of judges are preparing to decide, perhaps as soon as August, whether one court should receive similar IVC lawsuits filed against Bard for uniform pretrial management.

Courts receive IVC filter lawsuits

In case after case detailing injuries patients sustained after receiving the surgically implanted inferior vena cava filter, plaintiffs in these product liability lawsuits have heaped upon the court scientific evidence of device failure rates. As IVC lawsuits continue to be filed across the nation, a federal panel of judges are preparing to decide, perhaps as soon as August, whether one court should receive similar IVC lawsuits filed against Bard for uniform pretrial management.

New basis for Levaquin lawsuits

A federal panel of judges will decide after a July 30 hearing in San Francisco whether to centralize before a single judge numerous federal cases centered on a new basis for litigation against the maker of the antibiotic Levaquin. The U.S. Judicial Panel on Multidistrict Litigation grouped together Levaquin lawsuits in this manner in 2008 at a Minnesota trial court in regard to tendon injuries. The new reason that these actions may be centralized pertains to the drug's alleged nerve damage risk.

New basis for Levaquin lawsuits

Levaquin_Lawsuit_Damage.jpgA federal panel of judges will decide after a July 30 hearing in San Francisco whether to centralize before a single judge numerous federal cases centered on a new basis for litigation against the maker of the antibiotic Levaquin. The U.S. Judicial Panel on Multidistrict Litigation grouped together Levaquin lawsuits in this manner in 2008 at a Minnesota trial court in regard to tendon injuries. The new reason that these actions may be centralized pertains to the drug's alleged nerve damage risk.

Drug companies have patient safety role

The U.S. House of Representatives on Friday overwhelmingly approved the 21st Century Cures Act, sending to the U.S. Senate bipartisan legislation which, if it works as intended, "accelerates the discovery, development and delivery of life-saving and life-improving therapies, and transforms the quest for faster cures," according to a House Energy and Commerce Committee summary of the bill. The measure, dubbed H.R. 6, passed by a vote of 344-77.

Drug companies have patient safety role

Pharmaceutical_Injury_Lawsuit.jpgThe U.S. House of Representatives on Friday overwhelmingly approved the 21st Century Cures Act, sending to the U.S. Senate bipartisan legislation which, if it works as intended, "accelerates the discovery, development and delivery of life-saving and life-improving therapies, and transforms the quest for faster cures," according to a House Energy and Commerce Committee summary of the bill. The measure, dubbed H.R. 6, passed by a vote of 344-77.

What types of defects can lead to a products liability claim?

Products liability occurs when a defective product winds up in the possession of a consumer. Product liability claims typically arise after someone has be injured by the defective product. Many people understand this definition, but what, exactly, does it mean? Where is the line drawn, and what constitutes a defect?

What types of defects can lead to a products liability claim?

Products liability occurs when a defective product winds up in the possession of a consumer. Product liability claims typically arise after someone has be injured by the defective product. Many people understand this definition, but what, exactly, does it mean? Where is the line drawn, and what constitutes a defect?

Improving the way drugs are tested and marketed

Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.

Improving the way drugs are tested and marketed

Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.

Risperdal lawsuits from states move forward

Trial has been scheduled for April 2016 in the state of Kentucky's complaint against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc., in regard to the corporations' alleged misbranded promotion of the antipsychotic drug Risperdal (risperidone). J&J reported the trial timeline in its most recent quarterly report to the U.S. Securities and Exchange Commission.

Risperdal lawsuits from states move forward

Trial has been scheduled for April 2016 in the state of Kentucky's complaint against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc., in regard to the corporations' alleged misbranded promotion of the antipsychotic drug Risperdal (risperidone). J&J reported the trial timeline in its most recent quarterly report to the U.S. Securities and Exchange Commission.

What are possible side effects of metal hip replacements?

When metal-on-metal hip replacements first became available they were hailed as the wave of the future. What has since been discovered is that there have been a lot of instances of degradation and failure that have resulted in a wave of infections, revision surgeries and broader health complications.

What are possible side effects of metal hip replacements?

When metal-on-metal hip replacements first became available they were hailed as the wave of the future. What has since been discovered is that there have been a lot of instances of degradation and failure that have resulted in a wave of infections, revision surgeries and broader health complications.

Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions